Correlation Between Moleculin Biotech and Assembly Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Assembly Biosciences, you can compare the effects of market volatilities on Moleculin Biotech and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Assembly Biosciences.

Diversification Opportunities for Moleculin Biotech and Assembly Biosciences

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Moleculin and Assembly is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Moleculin Biotech and Assembly Biosciences

Given the investment horizon of 90 days Moleculin Biotech is expected to generate 2.48 times more return on investment than Assembly Biosciences. However, Moleculin Biotech is 2.48 times more volatile than Assembly Biosciences. It trades about 0.03 of its potential returns per unit of risk. Assembly Biosciences is currently generating about -0.14 per unit of risk. If you would invest  262.00  in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Moleculin Biotech  vs.  Assembly Biosciences

 Performance 
       Timeline  
Moleculin Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Moleculin Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Assembly Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Assembly Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Assembly Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Moleculin Biotech and Assembly Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moleculin Biotech and Assembly Biosciences

The main advantage of trading using opposite Moleculin Biotech and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.
The idea behind Moleculin Biotech and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios